Expression of fibroblast growth factor receptor 3 by fibroblast growth factor 2 in cultured chick embryo chondrocytes

Jo-Young Suh1, Young-Sam Kim, Jin-Woo Park

  • 1Department of Periodontology, School of Dentistry, Teachers' College, Kyungpook National University, Kyungpook, South Korea.

Insights

Fibroblast growth factor 2 (FGF2) up-regulates fibroblast growth factor receptor 3 (FGFR3) mRNA expression in chondrocytes. After reaching a peak, FGFR3 promotes chondrocyte differentiation, inhibiting longitudinal bone growth.

Area of Science:

  • Skeletal Biology
  • Endocrinology
  • Cell Biology

Background:

  • Fibroblast growth factor 2 (FGF2) and fibroblast growth factor receptor 3 (FGFR3) are known inhibitors of longitudinal bone growth.
  • The precise relationship between FGF2 and FGFR3 in bone development remains largely uncharacterized.

Purpose of the Study:

  • To investigate the relationship between FGF2 and FGFR3.
  • To examine the effect of FGF2 on FGFR3 mRNA expression in cultured chondrocytes from chick embryos.

Main Methods:

  • Chondrocytes were isolated from different regions of embryonic chick sterna and tibial growth plates.
  • Expression of FGFR1, FGFR3, type II, and type X collagen mRNA was analyzed.
  • FGFR3 mRNA expression was quantified after FGF2 administration at varying concentrations and culture durations.

Main Results:

  • FGFR3 mRNA expression was detected in all chondrocyte types and increased with FGF2 concentration up to a peak level.
  • FGFR3 expression kinetics varied between proliferative and hypertrophic chondrocytes.
  • FGF2 treatment led to an up-regulation of FGFR3 mRNA, with higher concentrations resulting in increased expression until a plateau.

Conclusions:

  • FGF2 up-regulates FGFR3 mRNA expression in a dose-dependent manner until a peak is reached.
  • In hypertrophic chondrocytes, FGFR3 signaling appears to drive differentiation, subsequently inhibiting longitudinal bone growth post-peak expression.